The DOI matches its Crossref record.
Distribution and excretion of fluoxetine and norfluoxetine in human milk
Open accessAbstract
Aims To characterize milk/plasma (M/P) ratio and infant dose, for fluoxetine and norfluoxetine, in breast‐feeding women taking fluoxetine for the treatment of depression, and to determine the plasma concentration of these drugs in their infants. Methods Fourteen women (mean age 32.2 years) taking fluoxetine (mean dose 0.51 mg kg−1 day−1 ) and their infants (mean age 3.4 months) were studied. Fluoxetine and norfluoxetine in plasma and milk were measured by high‐performance liquid chromatography over a 24 h dose interval in four patients, and by single point data collection in 10 patients. Infant exposure was estimated as the product of estimated milk production, and average drug concentration in milk, normalized to body weight and expressed as a percentage of the weight‐adjusted maternal dose. Results Mean M/P values of 0.68 (95% CI 0.52–0.84) and 0.56 (95% CI 0.35–0.77) were calculated for fluoxetine and norfluoxetine, respectively. Mean total infant exposure (fluoxetine equivalents) was estimated to be 6.81% (range 2.15–12%) of the weight‐adjusted maternal dose of fluoxetine. Contributions from fluoxetine and norfluoxetine were approximately equal. Fluoxetine (range 20–252 μg l−1 ) was detected in five of the nine infants from whom samples were collected, and norfluoxetine (range 17–187 μg l−1 ) was detected in seven of the nine infants. The highest of these concentrations was about 70% of the maternal plasma concentrations. Conclusions The mean combined dose of fluoxetine and norfluoxetine transmitted to infants via breast milk is below the 10% notional level of concern. However, there was considerable interpatient variability in estimated infant dose and in some of the patients, the dose was >10%. Further, since adverse effects have been observed in breast‐fed infants, careful monitoring of the infants is mandatory. Neonates exposed to these drugs in utero had higher concentrations of fluoxetine and norfluoxetine and are at greater risk of adverse effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Wisner, K. L., Parry, B. L., & Piontek, C. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp011542 · Cited by 666
The Transfer of Drugs and Therapeutics Into Human Breast Milk: An Update on Selected Topics
Sachs, H. C., COMMITTEE ON DRUGS, Frattarelli, D. A. C., Galinkin, J. L., Green, T. P., Johnson, T., Neville, K., Paul, I. M., & Van den Anker, J. (2013) · Pediatrics · doi:10.1542/peds.2013-1985 · Cited by 555
Pooled Analysis of Antidepressant Levels in Lactating Mothers, Breast Milk, and Nursing Infants
Weissman, A. M., Levy, B. T., Hartz, A. J., Bentler, S., Donohue, M., Ellingrod, V. L., & Wisner, K. L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.6.1066 · Cited by 329
New perspectives on the neurodevelopmental effects of SSRIs
Homberg, J. R., Schubert, D., & Gaspar, P. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.11.003 · Cited by 266
Depression during pregnancy and postpartum
Becker, M., Weinberger, T., Chandy, A., & Schmukler, S. (2016) · Current Psychiatry Reports · doi:10.1007/s11920-016-0664-7 · Cited by 263
Metadata
- Authors
- Kristensen, Ilett, Hackett, Yapp, Paech, & Begg
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 1999-10
- Volume
- 48
- Issue
- 4
- Pages
- 521-527
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W1482640626
- Cited by
- 163
- References
- 0
- FWCI
- 7.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Distribution and excretion of fluoxetine and norfluoxetine in human milk. https://app.cochat.ai/papers/10.1046/j.1365-2125.1999.00040.x
- The paper
- Kristensen, Ilett, Hackett, Yapp, Paech, & Begg. (1999). Distribution and excretion of fluoxetine and norfluoxetine in human milk. British Journal of Clinical Pharmacology. https://doi.org/10.1046/j.1365-2125.1999.00040.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.